[Molecular pathology - the key to precision oncology]

Area of Science:

• Oncology
• Genomics
• Molecular Pathology

Background:

• Advances in cancer genomics reveal specific molecular targets for therapy.
• Implementing predictive testing for these targets is crucial for routine healthcare.

Purpose of the Study:

• To establish regional and national platforms for comprehensive genomic tumor profiling.
• To ensure equitable patient access to targeted cancer therapies.

Main Methods:

• Developing novel IT infrastructures for genomic data analysis.
• Recruiting bioinformaticians and molecular biologists to hospital laboratories.
• Implementing linked analysis pipelines for tumor profiling.

Main Results:

• Creation of platforms for robust molecular diagnostic pathology.
• Enhanced capacity for wider clinical trial inclusion.
• Supplementation of national cancer registries with molecular real-world data.

Conclusions:

• The initiative by Genomic Medicine Sweden (GMS) will facilitate widespread genomic tumor profiling.
• This infrastructure is essential for advancing precision oncology and evaluating treatment efficacy.